# REPIN1

## Overview
REPIN1, or replication initiator 1, is a gene that encodes a polydactyl zinc-finger protein involved in various cellular processes, particularly in DNA replication and metabolic regulation. The protein encoded by REPIN1 is primarily localized in the cell nucleus, where it functions as a sequence-specific DNA binding protein, albeit with a relatively weak replication-enhancing activity (Ruschke2010Repin1). REPIN1 is notably expressed in liver and adipose tissues, where it plays a crucial role in adipogenesis, lipid metabolism, and glucose transport. It is implicated in the regulation of adipocyte size and lipid droplet formation, as well as in the modulation of fatty acid transporters such as CD36 (Ruschke2010Repin1). In the liver, REPIN1 is essential for lipid accumulation during regeneration and influences hepatocellular proliferation (Abshagen2018Liverspecific). Additionally, REPIN1 is involved in iron metabolism and osteoblast apoptosis, contributing to the pathophysiology of osteoporosis (Xia2023REPIN1). The gene's expression and function have significant implications for metabolic disorders, making it a potential target for therapeutic interventions.

## Structure


## Function
REPIN1, also known as replication initiator 1, is a gene that encodes a polydactyl zinc-finger protein involved in several critical cellular processes. In healthy human cells, REPIN1 is primarily active in the cell nucleus, where it plays a role in DNA replication. It acts as a sequence-specific DNA binding protein, potentially enhancing replication, although its replication-enhancing activity is considered weak (Ruschke2010Repin1).

REPIN1 is highly expressed in liver and adipose tissues, where it regulates genes involved in adipogenesis, lipid droplet formation, and glucose and fatty acid transport. During adipogenesis, REPIN1 expression increases, influencing adipocyte size and glucose uptake (Ruschke2010Repin1). In adipocytes, REPIN1 knockdown results in reduced lipid droplet size and decreased expression of fatty acid transporter CD36, affecting lipid metabolism (Ruschke2010Repin1).

In the liver, REPIN1 is significant for early lipid accumulation during liver regeneration, facilitating hepatocellular proliferation. Its deficiency leads to decreased expression of fatty acid transporters like CD36, impacting lipid uptake and storage (Abshagen2018Liverspecific). REPIN1 also plays a role in regulating iron metabolism and osteoblast apoptosis, which are crucial in the pathophysiology of osteoporosis (Xia2023REPIN1).

## Clinical Significance
Mutations and alterations in the expression of the REPIN1 gene have been associated with several metabolic disorders. In humans, a genetic deletion variant in REPIN1 is linked to a reduced risk of developing nonalcoholic fatty liver disease (NAFLD). Individuals homozygous for this deletion variant exhibit significantly lower NAFLD activity and fibrosis scores, suggesting a protective effect against the progression of NAFLD (Abshagen2020A).

In mouse models, REPIN1 deficiency has been shown to improve insulin sensitivity and glucose metabolism. This is achieved by reducing adipose tissue mass and inflammation, leading to decreased body weight and improved lipid metabolism. These findings indicate that REPIN1 plays a significant role in regulating adipose tissue function and metabolic processes, making it a potential target for obesity and metabolic syndrome treatments (Kunath2016Repin1).

REPIN1 also influences liver regeneration and lipid metabolism. In mice with liver-specific REPIN1 deficiency, there is reduced hepatic steatosis and improved insulin sensitivity, suggesting that REPIN1 impacts liver fat accumulation and glucose homeostasis (Abshagen2018Liverspecific). These insights highlight REPIN1's potential as a therapeutic target for metabolic diseases.


## References


[1. (Abshagen2018Liverspecific) Kerstin Abshagen, Bastian Degenhardt, Marie Liebig, Anna Wendt, Berit Genz, Ute Schaeper, Michael Stumvoll, Ute Hofmann, Marcus Frank, Brigitte Vollmar, and Nora Klöting. Liver-specific repin1 deficiency impairs transient hepatic steatosis in liver regeneration. Scientific Reports, November 2018. URL: http://dx.doi.org/10.1038/s41598-018-35325-3, doi:10.1038/s41598-018-35325-3. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-35325-3)

[2. (Kunath2016Repin1) Anne Kunath, Nico Hesselbarth, Martin Gericke, Matthias Kern, Sebastian Dommel, Peter Kovacs, Michael Stumvoll, Matthias Blüher, and Nora Klöting. Repin1 deficiency improves insulin sensitivity and glucose metabolism in db/db mice by reducing adipose tissue mass and inflammation. Biochemical and Biophysical Research Communications, 478(1):398–402, September 2016. URL: http://dx.doi.org/10.1016/j.bbrc.2016.07.038, doi:10.1016/j.bbrc.2016.07.038. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2016.07.038)

[3. (Xia2023REPIN1) Yu Xia, Gaoran Ge, Haixiang Xiao, Mingzhou Wu, Tianhao Wang, Chengyong Gu, Huilin Yang, and Dechun Geng. Repin1 regulates iron metabolism and osteoblast apoptosis in osteoporosis. Cell Death &amp; Disease, September 2023. URL: http://dx.doi.org/10.1038/s41419-023-06160-w, doi:10.1038/s41419-023-06160-w. This article has 3 citations.](https://doi.org/10.1038/s41419-023-06160-w)

[4. (Ruschke2010Repin1) Karen Ruschke, Monica Illes, Matthias Kern, Ingrid Klöting, Mathias Fasshauer, Michael R. Schön, Joanna Kosacka, Günther Fitzl, Peter Kovacs, Michael Stumvoll, Matthias Blüher, and Nora Klöting. Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes. Biochemical and Biophysical Research Communications, 400(2):246–251, September 2010. URL: http://dx.doi.org/10.1016/j.bbrc.2010.08.049, doi:10.1016/j.bbrc.2010.08.049. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2010.08.049)

[5. (Abshagen2020A) Kerstin Abshagen, Claudia Berger, Arne Dietrich, Tatjana Schütz, Christian Wittekind, Michael Stumvoll, Matthias Blüher, and Nora Klöting. A human repin1 gene variant: genetic risk factor for the development of nonalcoholic fatty liver disease. Clinical and Translational Gastroenterology, 11(1):e00114, January 2020. URL: http://dx.doi.org/10.14309/ctg.0000000000000114, doi:10.14309/ctg.0000000000000114. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.14309/ctg.0000000000000114)